Veradigm (NASDAQ:MDRX) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRXFree Report) in a research report released on Monday morning. The brokerage issued a hold rating on the software maker’s stock.

Separately, TD Cowen cut their price objective on Veradigm from $26.00 to $15.00 and set a buy rating for the company in a report on Tuesday, May 28th. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of Hold and an average target price of $12.00.

View Our Latest Analysis on Veradigm

Veradigm Trading Down 1.8 %

Shares of MDRX traded down $0.17 during mid-day trading on Monday, reaching $9.20. The company had a trading volume of 42,357 shares, compared to its average volume of 2,216,069. The company’s 50-day moving average is $9.58 and its 200-day moving average is $8.56. Veradigm has a twelve month low of $5.01 and a twelve month high of $14.09.

Institutional Investors Weigh In On Veradigm

Hedge funds and other institutional investors have recently bought and sold shares of the business. Innealta Capital LLC acquired a new position in Veradigm in the second quarter worth $38,000. Tyro Capital Management LLC acquired a new position in Veradigm during the 1st quarter worth about $9,055,000. Horrell Capital Management Inc. bought a new stake in Veradigm during the 1st quarter worth about $385,000. Meadow Creek Wealth Advisors LLC acquired a new stake in Veradigm in the 1st quarter valued at about $83,000. Finally, Vanguard Group Inc. raised its stake in shares of Veradigm by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after acquiring an additional 95,291 shares during the last quarter.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Stories

Analyst Recommendations for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.